Journal of controlled release : official journal of the Controlled Release SocietyFeb 20, 2026

Zinc-enhanced lipid nanoparticles for strong spleen-targeted mRNA delivery and improved immune response

mRNA Technology Weekly Brief ↗PubMed ↗DOI ↗

Updated Feb 22, 2026

Abstract

A library of 28 imidazole-based ionizable lipids was synthesized and screened, identifying A10-1 LNPs with high transfection efficiency.

The Zn-A10-1 LNPs exhibited enhanced structural stability and delivery performance through Zn coordination with the imidazole headgroup.
Improved cellular uptake and efficient endosomal escape were observed with the Zn-A10-1 LNPs.
Zn-A10-1 LNPs showed preferential accumulation in the spleen and robust activation of bone marrow-derived dendritic cells.
Vaccination with Zn-A10-1 LNPs induced memory T cell responses and elevated proinflammatory cytokine secretion.
In a melanoma model, Zn-A10-1 LNPs significantly suppressed tumor progression and increased infiltration of OVA-specific CD8 T cells.

Simplified

Lipid nanoparticles (LNPs) have emerged as a powerful nanoplatforms contributing to the success of mRNA vaccines. However, the rational design of lipid structures and the optimization of LNP composition, especially via metal-based adjuvants to boost extrahepatic delivery and immune responses, represent a promising yet technically challenging strategy. Herein, we developed a Zn(II)-adjuvanted imidazole-based LNP system that integrates rational lipid design with metal-coordinated self-assembly to achieve synergistic enhancement in delivery and immunogenicity. Initially, a library of 28 imidazole-based ionizable lipids was synthesized and screened, identifying A10-1 LNPs with a well-balanced lipid composition and high transfection efficiency. Furthermore, Zncoordination with the imidazole headgroup imparts Zn-A10-1 LNPs with enhanced structural stability and delivery performance, leading to improved cellular uptake, efficient endosomal escape, and preferential accumulation in the spleen. These attributes contributed to the robust activation of bone marrow-derived dendritic cells (BMDCs), induced memory T cell responses, and elevated proinflammatory cytokine secretion. In a melanoma model, vaccination with Zn-A10-1 LNPs markedly suppressed tumor progression and promoted the infiltration of OVA-specific CD8T cells. Overall, this study underscores the potential of Zn(II)-coordinated LNPs as effective nanoplatforms for extrahepatic mRNA vaccine delivery, offering a promising strategy for the mRNA-based vaccine design and immunotherapies. 2+ +

Full Text

Full text is available at the source.

View Full Text ↗

Funding

Competing interests

Declaration of competing interest The authors declare no competing financial interests or personal relationships that could have influenced the work presented in this paper.

PubMed

Zinc-enhanced lipid nanoparticles for strong spleen-targeted mRNA delivery and improved immune response

Abstract

Full Text

Funding

Competing interests

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief

Abstract

Full Text

Funding

Competing interests

Related papers

You found one interesting study. We’ll send the next 7.

What Lands in Your Inbox Each Week:

Recent issues from the mrna technology brief